91 related articles for article (PubMed ID: 22732573)
1. miRNAs, a potential target in the treatment of Non-Small-Cell Lung Carcinomas.
Malleter M; Jacquot C; Rousseau B; Tomasoni C; Juge M; Pineau A; Sakanian V; Roussakis C
Gene; 2012 Sep; 506(2):355-9. PubMed ID: 22732573
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate.
Jacquot C; Carbonnelle D; Tomasoni C; Papaconstadinou A; Roussis V; Roussakis C
Int J Oncol; 2004 Aug; 25(2):519-27. PubMed ID: 15254752
[TBL] [Abstract][Full Text] [Related]
3. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
5. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells.
Shin S; Cha HJ; Lee EM; Lee SJ; Seo SK; Jin HO; Park IC; Jin YW; An S
Int J Oncol; 2009 Jul; 35(1):81-6. PubMed ID: 19513554
[TBL] [Abstract][Full Text] [Related]
6. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
8. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
10. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
12. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
16. A novel large regulator RNA, B2, partially overlaps the HEF1/NEDD9/Cas-L gene.
Malleter M; Jacquot C; Moreau D; Tomasoni C; Tsvetanova M; Chinou I; Juge M; Pineau A; Le Pape P; Roussakis C
Int J Mol Med; 2010 Jun; 25(6):897-903. PubMed ID: 20428794
[TBL] [Abstract][Full Text] [Related]
17. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
19. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
20. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
